Loading next page...
/lp/elsevier/the-role-of-androgen-receptors-in-atherosclerosis-2y9XGM14YE
- Publisher
- Elsevier
- Copyright
- Copyright © 2017 Elsevier Ltd
- ISSN
- 0303-7207
- D.O.I.
- 10.1016/j.mce.2017.10.006
- Publisher site
- See Article on Publisher Site
Abstract
Male disadvantage in cardiovascular health is well recognised. However, the influence of androgens on atherosclerosis, one of the major causes of many life-threatening cardiovascular events, is not well understood. With the dramatic increase in clinical prescription of testosterone in the past decade, concerns about the cardiovascular side-effects of androgen supplementation or androgen deprivation therapy are increasing. Potential atheroprotective effects of testosterone could be secondary to (aromatase-mediated) conversion into oestradiol or, alternatively, to direct activation of androgen receptors (AR). Recent development of animal models with cell-specific AR knockout has indicated a complex role for androgen action in atherosclerosis. Most studies suggest androgens are atheroprotective but the precise role of AR remains unclear. Increased use of AR knockout models should clarify the role of AR in atherogenesis and, thus, lead to exploitation of this pathway as a therapeutic target.
Journal
Molecular and Cellular Endocrinology – Elsevier
Published: Apr 15, 2018
Recommended Articles
Loading...
References
-
Effects of androgens on coronary artery atherosclerosis and atherosclerosis-related impairment of vascular responsivenessAdams, M.R.; Williams, J.K.; Kaplan, J.R.
-
Natural androgens inhibit male atherosclerosis: a study in castrated, cholesterol-fed rabbitsAlexandersen, P.; Haarbo, J.; Byrjalsen, I.; Lawaetz, H.; Christiansen, C.
-
Dehydroepiandrosterone feeding prevents aortic fatty streak formation and cholesterol accumulation in cholesterol-fed rabbitArad, Y.; Badimon, J.J.; Badimon, L.; Hembree, W.C.; Ginsberg, H.N.
-
Trends in androgen prescribing in the United States, 2001 to 2011Baillargeon, J.; Urban, R.J.; Ottenbacher, K.J.; Pierson, K.S.; Goodwin, J.S.
-
Adverse events associated with testosterone administrationBasaria, S.; Coviello, A.D.; Travison, T.G.; Storer, T.W.; Farwell, W.R.; Jette, A.M.
-
Down-regulation of the c-myc proto-oncogene in inhibition of vascular smooth-muscle cell proliferation: a signal for growth arrest?Bennett, M.R.; Littlewood, T.D.; Hancock, D.C.; Evan, G.I.; Newby, A.C.
-
Functional testosterone receptors in plasma membranes of T cellsBenten, W.P.; Lieberherr, M.; Giese, G.; Wrehlke, C.; Stamm, O.; Sekeris, C.E.
-
Mechanisms of plaque formation and ruptureBentzon, J.F.; Otsuka, F.; Virmani, R.; Falk, E.
-
Dehydroepiandrosterone reverses systemic vascular remodeling through the inhibition of the Akt/GSK3-{beta}/NFAT axisBonnet, S.; Paulin, R.; Sutendra, G.; Dromparis, P.; Roy, M.; Watson, K.O.
-
Androgen receptor-dependent and independent atheroprotection by testosterone in male miceBourghardt, J.; Wilhelmson, A.S.K.; Alexanderson, C.; De Gendt, K.; Verhoeven, G.; Krettek, A.
-
Gender-specific differences in the effects of testosterone and estrogen on the development of atherosclerosis in rabbitsBruck, B.; Brehme, U.; Gugel, N.; Hanke, S.; Finking, G.; Lutz, C.
-
Testosterone treatment and coronary artery plaque volume in older men with low testosteroneBudoff, M.J.; Ellenberg, S.S.; Lewis, C.E.; Mohler, E.R.; Wenger, N.K.; Bhasin, S.
-
Angiogenesis in the atherosclerotic plaqueCamare, C.; Pucelle, M.; Negre-Salvayre, A.; Salvayre, R.
-
Cellular actions of testosterone in vascular cells: mechanism independent of aromatization to estradiolCampelo, A.E.; Cutini, P.H.; Massheimer, V.L.
-
Structural analysis of complementary DNA and amino acid sequences of human and rat androgen receptorsChang, C.S.; Kokontis, J.; Liao, S.T.
-
Estrogen reduces myointimal proliferation after balloon injury of rat carotid arteryChen, S.J.; Li, H.; Durand, J.; Oparil, S.; Chen, Y.F.
-
Selective DNA binding by the androgen receptor as a mechanism for hormone-specific gene regulationClaessens, F.; Verrijdt, G.; Schoenmakers, E.; Haelens, A.; Peeters, B.; Verhoeven, G.
-
New selective estrogen and androgen receptor modulatorsClarke, B.L.; Khosla, S.
-
Dihydrotestosterone promotes vascular cell adhesion molecule-1 expression in male human endothelial cells via a nuclear factor-kappaB-dependent pathwayDeath, A.K.; McGrath, K.C.Y.; Sader, M.A.; Nakhla, S.; Jessup, W.; Handelsman, D.J.
-
A Sertoli cell-selective knockout of the androgen receptor causes spermatogenic arrest in meiosisDe Gendt, K.; Swinnen, J.V.; Saunders, P.T.K.; Schoonjans, L.; Dewerchin, M.; Devos, A.; Tan, K.; Atanassova, N.; Claessens, F.; Lecureuil, C.; Heyns, W.; Carmeliet, P.; Guillou, F.; Sharpe, R.M.; Verhoeven, G.
-
Cardiovascular toxicities of performance-enhancing substances in sportsDhar, R.; Stout, C.W.; Link, M.S.; Homoud, M.K.; Weinstock, J.; Estes, N.A.M.
-
Androgens and coronary artery disease. Chapter 16Dixit, K.C.S.; Wu, J.; Smith, L.B.; Hadoke, P.W.F.; Wu, F.C.W.
-
Inhibition of accelerated coronary atherosclerosis with dehydroepiandrosterone in the heterotopic rabbit model of cardiac transplantationEich, D.M.; Nestler, J.E.; Johnson, D.E.; Dworkin, G.H.; Ko, D.; Wechsler, A.S.
-
The androgen receptor confers protection against diet-induced atherosclerosis, obesity, and dyslipidemia in female miceFagman, J.B.
-
Coronary plaque disruptionFalk, E.; Shah, P.K.; Fuster, V.
-
Non-genomic actions of androgensForadori, C.D.; Weiser, M.J.; Handa, R.J.
-
Androgens stimulate endothelial progenitor cells through an androgen receptor-mediated pathwayForesta, C.; Zuccarello, D.; De Toni, L.; Garolla, A.; Caretta, N.; Ferlin, A.
-
A UK epidemic of testosterone prescribing, 2001-2010Gan, E.H.; Pattman, S.H.P.; Quinton, R.
-
Chemistry and structural biology of androgen receptorGao, W.; Bohl, C.E.; Dalton, J.T.
-
Reduction of atherosclerosis by administration of dehydroepiandrosterone. A study in the hypercholesterolemic New Zealand white rabbit with aortic intimal injuryGordon, G.B.; Bush, D.E.; Weisman, H.F.
-
Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: the Rotterdam StudyHak, A.E.; Witteman, J.C.M.; De Jong, F.H.; Geerlings, M.I.; Hofman, A.; Pols, H.A.P.
-
Effect of testosterone on plaque development and androgen receptor expression in the arterial vessel wallHanke, H.; Lenz, C.; Hess, B.; Spindler, K.D.; Weidemann, W.
-
Inflammation, atherosclerosis, and coronary artery diseaseHansson, G.K.
-
Testosterone inhibits tumor necrosis factor-alpha-induced vascular cell adhesion molecule-1 expression in human aortic endothelial cellsHatakeyama, H.; Nishizawa, M.; Nakagawa, A.; Nakano, S.; Kigoshi, T.; Uchida, K.
-
Endogenous androgen deficiency enhances diet-induced hypercholesterolemia and atherosclerosis in low-density lipoprotein receptor-deficient miceHatch, N.W.; Srodulski, S.J.; Chan, H.W.; Zhang, X.; Tannock, L.R.; King, V.L.
-
Dehydroepiandrosterone retards atherosclerosis formation through its conversion to estrogen: the possible role of nitric oxideHayashi, T.; Tsaki, T.; Muto, E.; Kano, H.; Asai, Y.; Thakur, N.K.
-
A frame-shift mutation in the androgen receptor gene causes complete androgen insensitivity in the testicular-feminized mouseHe, W.W.; Kumar, M.V.; Tindall, D.J.
-
Androgen receptor (AR) coregulators: an overviewHeinlein, C.A.; Chang, C.
-
Experimental rat and mouse carotid artery surgery: injury & remodeling studiesHolt, A.W.; Tulis, D.A.
-
Canine vascular tissues are targets for androgens, estrogens, progestins, and glucocorticoidsHorwitz, K.B.; Horwitz, L.D.
-
New therapy via targeting androgen receptor in monocytes/macrophages to battle atherosclerosisHuang, C.K.; Pang, H.; Wang, L.; Niu, Y.; Luo, J.; Chang, E.
-
Androgen receptor (AR) in cardiovascular diseasesHuang, C.-K.; Lee, S.-O.; Chang, E.; Pang, H.; Chang, C.
-
Adrenal androgen dehydroepiandrosterone sulfate inhibits vascular remodeling following arterial injuryIi, M.; Hoshiga, M.; Negoro, N.; Fukui, R.; Nakakoji, T.; Kohbayashi, E.
-
Nuclear import of the human androgen receptorJenster, G.; Trapman, J.; Brinkmann, A.O.
-
The effects of testosterone on risk factors for, and the mediators of, the atherosclerotic processJones, T.H.; Saad, F.
-
Altered circulating hormone levels, endothelial function and vascular reactivity in the testicular feminished mouseJones, R.D.; Pugh, P.J.; Hall, J.; Channer, K.S.; Jones, T.H.
-
The influence of testosterone upon vascular reactivityJones, R.D.; Jones, T.H.; Channer, K.S.
-
Coronary atherosclerosis in indigenous South American Tsimane: a cross-sectional cohort studyKaplan, H.; Thompson, R.C.; Trumble, B.C.; Wann, L.S.; Allam, A.H.; Beheim, B.; Frohlich, B.; Sutherland, M.L.; Sutherland, J.D.; Stieglitz, J.; Rodriguez, D.E.; Michalik, D.E.; Rowan, C.J.; Lombardi, G.P.; Bedi, R.; Garcia, A.R.; Min, J.K.; Narula, J.; Finch, C.E.; Gurven, M.; Thomas, G.S.
-
New Insights into the Tyrolean man's origin and phenotype as inferred by whole genome sequencingKeller, A.; Graefens, A.; Ball, M.; Matzas, M.; Boisguerin, V.; Maixner, F.
-
Quantitative 3-dimensional imaging of murine neointimal and atherosclerotic lesions by optical projection tomographyKirkby, N.S.; Low, L.; Seckl, J.R.; Walker, B.R.; Webb, D.J.; Hadoke, P.W.F.
-
Testosterone and cardiovascular diseaseKloner, R.A.; Carson, C.; Dobs, A.; Kopecky, S.; Mohler, E.R.
-
Effect of testosterone on atherogenesis in cholesterol-fed rabbits with similar plasma cholesterol levelsLarsen, B.A.; Nordestgaard, B.G.; Stender, S.; Kjeldsen, K.
-
The therapeutic value of testosterone propionate in angina pectorisLevine, S.A.; Likoff, W.B.
-
Regulation of atherosclerotic plaque growth and stability by testosterone and its receptor via influence of inflammatory reactionLi, S.; Li, X.; Li, Y.
-
Inflammation and immunity in diseases of the arterial tree. Players and layersLibby, P.; Hansson, G.K.
-
Sex hormones, insulin, lipids, and prevalent ischemic heart diseaseLichtenstein, M.J.; Yarnell, J.W.; Elwood, P.C.; Beswick, A.D.; Sweetnam, P.M.; Marks, V.
-
Androgens and cardiovascular diseaseLiu, P.Y.; Death, A.K.; Handelsman, D.J.
-
Testosterone induces apoptosis in vascular smooth muscle cells via extrinsic apoptotic pathway with mitochondria-generated reactive oxygen species involvementLopes, R.A.M.; Neves, K.B.; Pestana, C.R.; Queiroz, A.L.; Zanotto, C.Z.; Chignalia, A.Z.
-
Cloning of human androgen receptor complementary DNA and localization to the X chromosomeLubahn, D.B.; Joseph, D.R.; Sullivan, P.M.; Willard, H.F.; French, F.S.; Wilson, E.M.
-
X-linked gene for testicular feminization in the mouseLyon, M.F.; Hawkes, S.G.
-
Testosterone as a protective factor against atherosclerosis - immunomodulation and influence upon plaque development and stabilityMalkin, C.J.; Pugh, P.J.; Jones, R.D.; Jones, T.H.; Channer, K.S.
-
Androgen deprivation therapy and the risk of coronary heart disease and heart failure in patients with prostate cancer. A nested case-control study in UK primary careMartin-Merino, E.; Johansson, S.; Morris, T.; Garcia-Rodriguez, L.A.
-
Structural evidence for ligand specificity in the binding domain of the human androgen receptor. Implications for pathogenic gene mutationsMatias, P.M.; Donner, P.; Coelho, R.; Thomaz, M.; Peixoto, C.; Macedo, S.
-
Androgen exposure increases human monocyte adhesion to vascular endothelium and endothelial cell expression of vascular cell adhesion molecule-1McCrohon, J.A.; Jessup, W.; Handelsman, D.J.; Celermajer, D.S.
-
Androgen receptor expression is greater in macrophages from male than from female donors. A sex difference with implications for atherogenesisMcCrohon, J.A.; Death, A.K.; Nakhla, S.; Jessup, W.; Handelsman, D.J.; Stanley, K.K.
-
Androgen-induced progression of arterial calcification in apolipoprotein E-null mice is uncoupled from plaque growth and lipid levelsMcRobb, L.; Handelsman, D.J.; Heather, A.K.
-
Angiogenesis in atherosclerosis: gathering evidence beyond speculationMoulton, K.S.
-
Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient miceMoulton, K.S.; Heller, E.; Konerding, M.A.; Flynn, E.; Palinski, W.; Folkman, J.
-
Aromatase in atherosclerotic lesions of human aortaMurakami, H.; Harada, N.; Sasano, H.
-
Testosterone inhibits early atherogenesis by conversion to estradiol: critical role of aromataseNathan, L.; Shi, W.; Dinh, H.; Mukherjee, T.K.; Wang, X.; Lusis, A.J.
-
Physiological testosterone replacement therapy attenuates fatty streak formation and improves high-density lipoprotein cholesterol in the Tfm mouse: an effect that is independent of the classic androgen receptorNettleship, J.E.; Jones, T.H.; Channer, K.S.; Jones, R.D.
-
Fibrous cap formation or destruction–the critical importance of vascular smooth muscle cell proliferation, migration and matrix formationNewby, A.C.; Zaltsman, A.B.
-
Dihydrotestosterone decreases tumor necrosis factor-alpha and lipopolysaccharide-induced inflammatory response in human endothelial cellsNorata, G.D.; Tibolla, G.; Seccomandi, P.M.; Poletti, A.; Catapano, A.L.
-
Dihydrotestosterone suppresses foam cell formation and attenuates atherosclerosis developmentQiu, Y.; Yanase, T.; Hu, H.; Tanaka, T.; Nishi, Y.; Liu, M.
-
Dihydrotestosterone inhibits lectin-like oxidized-LDL receptor-1 expression in aortic endothelial cells via a NF-κB/AP-1-mediated mechanismQiu, Y.; Tanaka, T.; Nawata, H.; Yanase, T.
-
Non-classical actions of testosterone: an updateRahman, F.; Christian, H.C.
-
Expression of Androgen Receptor Target Genes in Skeletal MuscleRana, K.; Lee, N.K.L.; Zajac, J.D.; Maclean, H.E.
-
Atherosclerosis–an inflammatory diseaseRoss, R.
-
A sex-specific role for androgens in angiogenesisSieveking, D.P.; Lim, P.; Chow, R.W.Y.; Dunn, L.L.; Bao, S.; McGrath, K.C.Y.
-
Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein ESmith, J.D.; Trogan, E.; Ginsberg, M.; Grigaux, C.; Tian, J.; Miyata, M.
-
A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on ArteriosclerosisStary, H.C.; Chandler, A.B.; Glagov, S.; Guyton, J.R.; Insull, W.; Rosenfeld, M.E.
-
Endogenous testosterone attenuates neointima formation after moderate coronary balloon injury in male swineTharp, D.L.; Masseau, I.; Ivey, J.; Ganjam, V.K.; Bowles, D.K.
-
Atherosclerosis across 4000 years of human history: the Horus study of four ancient populationsThompson, R.C.; Allam, A.H.; Lombardi, G.P.; Wann, L.S.; Sutherland, M.L.; Sutherland, J.D.
-
Ultrastructural changes in the comb and aorta of chicks fed excess testosteroneToda, T.; Toda, Y.; Cho, B.H.; Kummerow, F.A.
-
Mouse spermatogenesis requires classical and nonclassical testosterone signalingToocheck, C.; Clister, T.; Shupe, J.; Crum, C.; Ravindranathan, P.; Lee, T.-K.; Ahn, J.-M.; Raj, G.V.; Sukhwani, M.; Orwig, K.E.; Walker, W.H.
-
Susceptibility to early atherosclerosis in male mice is mediated by estrogen receptor αVillablanca, A.; Lubahn, D.; Shelby, L.; Lloyd, K.; Barthold, S.
-
Increased intimal hyperplasia after vascular injury in male androgen receptor-deficient miceWilhelmson, A.S.
-
Dehydroepiandrosterone inhibits human vascular smooth muscle cell proliferation independent of ARs and ERsWilliams, M.R.; Ling, S.; Dawood, T.; Hashimura, K.; Dai, A.; Li, H.
-
Effects of androgen treatment on the male rat aortaWolinsky, H.
-
Modulation of neointimal lesion formation by endogenous androgens is independent of vascular androgen receptorWu, J.; Hadoke, P.W.F.; Mair, I.; Lim, W.G.; Miller, E.; Denvir, M.A.
-
Influence of androgen receptor in vascular cells on reperfusion following hindlimb ischaemiaWu, J.; Hadoke, P.W.F.; Takov, K.; Korczak, A.; Denvir, M.A.; Smith, L.B.
-
Androgens and coronary artery diseaseWu, F.C.W.; Von Eckardstein, A.
-
Effect of dehydroepiandrosterone on atherosclerosis in apolipoprotein E-deficient miceYamakawa, T.; Ogihara, K.; Kakamura, M.; Utsunomiya, H.; Kadonosono, K.; Kishikawa, S.
-
Generation and characterization of androgen receptor knockout (ARKO) mice: an in vivo model for the study of androgen functions in selective tissuesYeh, S.; Tsai, M.-Y.; Xu, Q.; Mu, X.-M.; Lardy, H.; Huang, K.-E.
-
Androgen receptor-dependent activation of endothelial nitric oxide synthase in vascular endothelial cells: role of phosphatidylinositol 3-kinase/Akt pathwayYu, J.; Akishita, M.; Eto, M.; Ogawa, S.; Son, B.K.; Kato, S.
-
Androgen deprivation therapy and cardiovascular disease: what is the linking mechanism?Zareba, P.; Duivenvoorden, W.; Leong, D.P.; Pinthus, J.H.
-
Androgen deprivation therapy for prostate cancer is associated with cardiovascular morbidity and mortality: a meta-analysis of population-based observational studiesZhao, J.; Zhu, S.; Sun, L.; Meng, F.; Zhao, L.; Zhao, Y.
-
Ablation of the androgen receptor from vascular smooth muscle cells demonstrates a role for testosterone in vascular calcificationZhu, D.; Hadoke, P.W.F.; Wu, J.; Vesey, A.T.; Lerman, D.A.; Dweck, M.R.; Newby, D.E.; Smith, L.B.; MacRae, V.E.
@Phil_Robichaud
@deepthiw
@JoseServera